Skip to main content
. 2017 Aug 14;2017(8):CD012763. doi: 10.1002/14651858.CD012763

Kvolik 2012a.

Methods Study design: prospective, randomized study
Sample size calculation: no information available
Participants Number of randomized participants: 36
Inclusion criteria: undergoing thyroidectomy
Exclusion criteria: no information available
Interventions Anaesthesia: propofol and fentanyl for both induction and maintenance
NMBA: single intubating dose: rocuronium 0.6 mg/kg; maintenance dose: rocuronium 0.1 mg/kg
Comparison: sugammadex 2 mg/kg (n = 17) vs neostigmine 50 µg/kg (n = 19)
Administration time of sugammadex or neostigmine: reappearance of T2
Outcomes Recovery of TOFR > 90% of baseline, recovery of cough reflexes enabling safe extubation, spontaneous minute volume at the time of extubation
Notes Publication type: meeting abstract
Country: Croatia
Conversions: none
Handling of adverse events: No discrepancy exists between AEs presented in the meeting abstract and those reported in this review
Authors’ conclusions: Recovery of cough reflexes was faster and respiration more efficient in patients receiving sugammadex. A safe extubation was determined by age, TOF recovery, and effects of other anaesthetics
Contact: first trial author Slavica Kvolik contacted by email: slavica.kvolik@os.t‐com.hr on 14.10.2015; no reply received
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "Randomized"; no further information available
Allocation concealment (selection bias) Unclear risk Unable to assess owing to insufficient information
Blinding of participants (performance bias) Unclear risk Unable to assess owing to insufficient information
Blinding of personnel (performance bias) Unclear risk Unable to assess owing to insufficient information
Blinding of primary outcome assessment (detection bias) Unclear risk Unable to assess owing to insufficient information
Blinding of safety assessment (detection bias) Unclear risk Unable to assess owing to insufficient information
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Unable to assess owing to insufficient information
Selective reporting (reporting bias) Low risk Study protocol not available, but published meeting abstract clearly includes all expected outcomes
Funding bias Unclear risk Unable to assess owing to insufficient information
Other bias Unclear risk No information on sample size calculation. No differences regarding participant characteristics and preparative FT4, FT3, and TSH levels between groups